Developer docs
API playgroundTry for free, no card

Search company profiles

University Cancer & Blood Center

Full company profile

uuid000l6tt

Namestring
University Cancer & Blood Center
Legal namestring
University Cancer & Blood Center
Company typeenum
Private
Founded yearint
1981
Descriptiontext

University Cancer & Blood Center (UCBC) is a private, multi-specialty oncology and hematology practice headquartered in Athens, Georgia, delivering comprehensive cancer care across 13 locations in Northeast Georgia. The practice traces its origins to 1981 and operates as a vertically integrated provider combining medical oncology, radiation oncology, surgical oncology, hematology, and a Comprehensive Breast Health Program under a single coordinated care model. Its service portfolio spans core treatment modalities (chemotherapy, external beam radiation, brachytherapy, systemic radiopharmaceuticals, tumor surgery), specialized clinics (Theranostics — the first in Georgia outside a hospital setting — Melanoma Clinic, High-Risk GI Clinic, Athens Brain Center, Acute Care Clinic), and supporting infrastructure including an in-house pharmacy, laboratory, CT imaging, flow cytometry, molecular testing, genetic counseling, and a Live Well integrative care program.

UCBC generates revenue primarily through professional services billed to insurance and patients across its multi-site clinical footprint, supplemented by participation in a clinical trials program covering 20+ cancer types through its NCI-affiliated research program. Distribution is direct and regional: patients access care via scheduled appointments, physician referrals, and hospital partnerships with Piedmont Athens Regional and St. Mary's, where UCBC's inpatient advanced practice providers serve as on-site care coordinators. Marketing emphasizes community presence and physician credentials rather than price competition, supported by a NavigatingCare patient portal and an active SNMMI-recognized Clinical Radiopharmaceutical Therapy Center of Excellence designation. The practice is governed as a physician-led private entity with no identified parent company or institutional investor ownership.

Customer acquisition is fundamentally regional, anchored in Northeast Georgia with selected extension into Greater Atlanta metro counties (e.g., Gwinnett and Newton). Recent operating cadence — including the Snellville opening (January 2024), Oconee Imaging Center (May 2025), construction of a new Athens Comprehensive Cancer Center, the addition of a board-certified surgical oncologist in 2023, and the SNMMI Center of Excellence designation in April 2026 — indicates a multi-year build-out of clinical capacity and credentials.

Short descriptiontext

University Cancer & Blood Center is a private, multi-specialty oncology and hematology practice operating 13 locations across Northeast Georgia, delivering integrated medical, radiation, and surgical oncology plus specialized programs in theranostics, breast health, and clinical trials.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
251–500
akta.pro rankint
HeadquartersAthens, United States
HQ citystring
Athens
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices13 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
oncology services, radiation therapy, hematology care, cancer treatment, clinical trials
Industry3 codes
1Ambulatory Oncology Centers (Outpatient Chemo/Radiation)
CodeHLAFABAIPrimaryYes
2Nuclear Medicine Clinical Services & Therapy Centers
CodeHLAIAGAIPrimaryNo
3Hospital-Integrated Cancer Centers (Acute Oncology Programs)
CodeHLAFAAAMPrimaryNo
NAICS code2 codes
  • Diagnostic Imaging Centers621512
  • Medical and Diagnostic Laboratories6215
SIC code2 codes
  • Services-Specialty Outpatient Facilities, Nec8093
  • Services-Offices & Clinics Of Doctors Of Medicine8011
Product category
Oncology and Hematology Healthcare Services
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1Patient Care Services
TypeProfessional Services
Description

Revenue generated from comprehensive oncology and hematology healthcare services including medical oncology, radiation oncology, surgical oncology, diagnostic imaging, laboratory services, pharmacy, and supportive care. Billed through insurance reimbursement and patient payments.

universitycancer.com
2Clinical Trial Participation
TypeProfessional Services
Description

Revenue and resources obtained through participation in clinical trials, providing access to investigational therapies while contributing to cancer research advancement.

universitycancer.com
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales, Supply Chain
GTM typeB2C
B2C
Offering typeServices
Services
Core offering1 text field

University Cancer & Blood Center (UCBC) is a multi-specialty oncology and hematology practice delivering comprehensive cancer care including medical oncology, surgical oncology, radiation oncology, hematology, and specialized programs such as breast health, theranostics, melanoma, and high-risk GI clinics. The practice operates across 13 locations in Northeast Georgia with an Athens-based Comprehensive Cancer Center that co-locates infusion, imaging, laboratory, pharmacy, and supportive services.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • 92% of breast cancer survivors had progression of secondary lymphedema stopped through three years using L-Dex Technology
Product overview1 text field

University Cancer & Blood Center (UCBC) is a multi-specialty oncology and hematology practice offering a comprehensive, vertically integrated cancer care ecosystem. The core portfolio consists of three primary treatment pillars—Medical Oncology (chemotherapy and drug-based therapies), Radiation Oncology (external beam, brachytherapy, and systemic radiopharmaceuticals), and Surgical Oncology—augmented by specialized programs including the Comprehensive Breast Health Program (3D mammography, breast surgery, lymphedema management), Theranostics (first in Georgia outside a hospital), Athens Brain Center, Melanoma Clinic, High-Risk GI Clinic, and Hematology services. UCBC delivers care through 13 area locations across Northeast Georgia, anchored by its Athens Comprehensive Cancer Center where private infusion, in-house laboratory, CT imaging, molecular testing, genetic counseling, UCBC Pharmacy, and the Acute Care Clinic are co-located. The Live Well integrative care program provides psychosocial, nutritional, and financial support, while an active Clinical Trials program spans 20+ cancer types. Patient-facing digital tools include a NavigatingCare patient portal and a bill payment portal, supported by an Inpatient APP program at affiliated hospitals. The organization traces its roots to Athens, Georgia since 1981.

Product and service15 records
1Medical Oncology
CategoryCore Service
Description

Comprehensive cancer treatment using chemotherapy, hormone therapy, and other drug-based therapies. UCBC oncologists guide patients through diagnosis, treatment planning, and post-treatment care.

2Radiation Oncology
CategoryCore Service
Description

Treatment using precisely targeted high-energy radiation to kill cancer cells, including external beam radiation therapy, brachytherapy, and systemic radiopharmaceuticals (LUTATHERA, Xofigo, Pluvicto).

3Surgical Oncology
CategoryCore Service
Description

Surgical removal of tumors and affected tissues, including liver, melanoma, pancreatic, gastrointestinal, retroperitoneal sarcoma, neuroendocrine tumors, and gallbladder cancers.

4Hematology
CategoryCore Service
Description

Treatment of benign and malignant blood disorders including anemias, blood transfusions, bone marrow transplantations, hemophilia, leukemias, lymphomas, multiple myeloma, and thrombotic conditions.

5Comprehensive Breast Health Program
CategorySpecialized Program
Description

Multidisciplinary breast health services including 3D mammography screening and diagnostics, high-risk breast program with genetic testing and counseling, breast surgery, medical and radiation oncology, and lymphedema management.

6Theranostics
CategorySpecialized Program
Description

First cancer center in Georgia to offer Theranostics outside a hospital setting, combining diagnostic PET scan imaging with targeted radiopharmaceutical therapy (LUTATHERA, Xofigo, Pluvicto) for neuroendocrine tumors and prostate cancer.

7High-Risk GI Clinic
CategorySpecialized Clinic
Description

Gastrointestinal cancer risk assessment, screening, and surveillance for patients with pre-cancerous conditions or genetic risk factors, including colorectal, gastric, or pancreatic cancers.

8Melanoma Clinic
CategorySpecialized Clinic
Description

Multidisciplinary melanoma treatment program involving dermatologists, medical oncologists, surgical oncologists, radiation oncologists, and ENT specialists, including SPECT imaging for lymph node identification.

9Athens Brain Center
CategorySpecialized Division
Description

Brain cancer treatment division offering radiation therapy and other advanced treatments for brain and spinal cord tumors, led by Dr. Gordon O. Schoenfeld.

10Acute Care Clinic
CategoryUrgent Care Service
Description

Same-day oncology urgent care clinic for UCBC patients experiencing adverse cancer treatment side effects, staffed by oncology-trained providers.

11UCBC Pharmacy
CategoryIn-House Service
Description

Full-service retail pharmacy within the Comprehensive Cancer Center staffed with certified pharmacists, accepting most major insurance and stocking difficult-to-find medications.

12In-House Laboratory and Imaging Services
CategoryIn-House Diagnostic Service
Description

In-house diagnostic capabilities including CT imaging, flow cytometry, molecular testing, and genetic counseling, enabling rapid diagnosis and treatment planning.

13Live Well Integrative Care Program
CategorySupport Program
Description

Holistic patient support program including integrative therapies, psychosocial counseling, nutrition counseling, palliative care, and financial support services.

14Clinical Trials Program
CategoryResearch Program
Description

Active clinical trial program across 20+ cancer types, described as the second most prolific clinical trial facility in Georgia.

15Inpatient Advanced Practice Provider Program
CategoryInpatient Care Service
Description

On-site APP staff at Piedmont Athens and St. Mary's Hospitals serving as personal patient advocates to coordinate care for hospitalized UCBC patients.

Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership8 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-01-01
Description

UCBC partnered with University Health Alliance to open the High-Risk GI Clinic, a state-of-the-art program featuring acclaimed physicians and experts in oncology and gastroenterology for patients at high risk of gastrointestinal cancer.

2Cancer Foundation of Northeast Georgia
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2005-01-01
Description

UCBC established the Cancer Foundation of Northeast Georgia in 2005 to help offset the extreme financial burden that a cancer diagnosis and subsequent treatment can place on families. The foundation benefits not only UCBC patients but all those within the Northeast Georgia region, providing financial support services.

universitycancer.com
Strategic tierCoreTypeStrategic or Co-development Partner
Description

UCBC maintains affiliation with the National Cancer Institute (NCI), operating as a clinical trial site and part of a global community of cancer researchers working toward common goals in cancer treatment advancement.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

UCBC's Inpatient APP staff are on-site as personal patient advocates at Piedmont Athens Hospital to coordinate care and optimize outcomes for UCBC patients receiving hospital treatment.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

UCBC's Inpatient APP staff are on-site as personal patient advocates at St. Mary's Hospital to coordinate care and optimize outcomes for UCBC patients receiving hospital treatment.

Strategic tierSecondaryTypeStrategic or Co-development Partner
Description

UCBC collaborates with ENT of Athens for multidisciplinary melanoma treatment, particularly for melanomas on the head and neck requiring facial plastic surgery expertise.

Strategic tierSecondaryTypeStrategic or Co-development Partner
Description

UCBC collaborates with dermatology specialists as part of the multidisciplinary melanoma clinic for skin assessment, biopsy, and ongoing dermatology care.

Strategic tierMinorTypeOthers
Description

UCBC receives community recognition through Choice Awards Athens.

Recent move9 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Large independent community oncology practice serving Tennessee with medical, radiation, and gynecologic oncology across multiple locations. Closely comparable multi-site, physician-led oncology model serving a regional catchment area.

TypeDirect peer
Description

Largest independent oncology and hematology practice in the United States, operating nearly 100 locations across Florida. Closely comparable vertically integrated model with in-house lab, imaging, pharmacy, and clinical trials program.

TypeDirect peer
Description

Independent community oncology practice operating across Maryland with medical oncology, radiation oncology, and clinical trials. Comparable multi-location, physician-led regional model with similar payer mix dynamics.

TypeDirect peer
Description

Independently owned community oncology and hematology practice serving the Greater Cincinnati tri-state area. Directly comparable independent multi-specialty practice with infusion, clinical trials, and supportive care services.

TypeBroad incumbent
Description

PE-backed platform supporting independent community oncology practices with practice management, technology, and payer contracting. Relevant as both a competitor and a potential roll-up partner for UCBC.

TypeBroad incumbent
Description

PE-backed partnership platform for independent community oncology practices, providing capital, technology, and operational support. Comparable as a consolidation alternative facing UCBC.

TypeBroad incumbent
Description

National Cancer Institute-designated Comprehensive Cancer Center and academic oncology hub in metropolitan Atlanta. Direct competitor for complex oncology cases in UCBC's Georgia catchment, including for Theranostics and clinical trials.

TypeRegional player
Description

Hospital-affiliated oncology practice within the Piedmont Healthcare system in Georgia. Direct regional competitor sharing the same hospital partnership ecosystem as UCBC.

TypeRegional player
Description

Independent community oncology practice serving Northwest Georgia and metro Atlanta suburbs. Comparable independent, multi-site model in a different but adjacent Georgia geography.

10The US Oncology Network
TypeBroad incumbent
Description

McKesson-affiliated network of independent community oncology practices offering practice management, technology, and drug distribution. Comparable as a competing affiliation model for community oncologists.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers5 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles6 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries2 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance5 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

University Cancer & Blood Center

Oncology and Hematology Healthcare Servicesuniversitycancer.com

University Cancer & Blood Center is a private, multi-specialty oncology and hematology practice operating 13 locations across Northeast Georgia, delivering integrated medical, radiation, and surgical oncology plus specialized programs in theranostics, breast health, and clinical trials.

What University Cancer & Blood Center does

University Cancer & Blood Center (UCBC) is a private, multi-specialty oncology and hematology practice headquartered in Athens, Georgia, delivering comprehensive cancer care across 13 locations in Northeast Georgia. The practice traces its origins to 1981 and operates as a vertically integrated provider combining medical oncology, radiation oncology, surgical oncology, hematology, and a Comprehensive Breast Health Program under a single coordinated care model. Its service portfolio spans core treatment modalities (chemotherapy, external beam radiation, brachytherapy, systemic radiopharmaceuticals, tumor surgery), specialized clinics (Theranostics — the first in Georgia outside a hospital setting — Melanoma Clinic, High-Risk GI Clinic, Athens Brain Center, Acute Care Clinic), and supporting infrastructure including an in-house pharmacy, laboratory, CT imaging, flow cytometry, molecular testing, genetic counseling, and a Live Well integrative care program.

UCBC generates revenue primarily through professional services billed to insurance and patients across its multi-site clinical footprint, supplemented by participation in a clinical trials program covering 20+ cancer types through its NCI-affiliated research program. Distribution is direct and regional: patients access care via scheduled appointments, physician referrals, and hospital partnerships with Piedmont Athens Regional and St. Mary's, where UCBC's inpatient advanced practice providers serve as on-site care coordinators. Marketing emphasizes community presence and physician credentials rather than price competition, supported by a NavigatingCare patient portal and an active SNMMI-recognized Clinical Radiopharmaceutical Therapy Center of Excellence designation. The practice is governed as a physician-led private entity with no identified parent company or institutional investor ownership.

Customer acquisition is fundamentally regional, anchored in Northeast Georgia with selected extension into Greater Atlanta metro counties (e.g., Gwinnett and Newton). Recent operating cadence — including the Snellville opening (January 2024), Oconee Imaging Center (May 2025), construction of a new Athens Comprehensive Cancer Center, the addition of a board-certified surgical oncologist in 2023, and the SNMMI Center of Excellence designation in April 2026 — indicates a multi-year build-out of clinical capacity and credentials.

University Cancer & Blood Center firmographics

Firmographics
Name
University Cancer & Blood Center
Legal name
University Cancer & Blood Center
Website
https://universitycancer.com
Company type
Private
Founded year
1981
Operating status
Operating
Headcount range
251–500 employees
Short description
University Cancer & Blood Center is a private, multi-specialty oncology and hematology practice operating 13 locations across Northeast Georgia, delivering integrated medical, radiation, and surgical oncology plus specialized programs in theranostics, breast health, and clinical trials.
Ownership category
akta.pro rank

University Cancer & Blood Center industry classification

Industry
Product category
Oncology and Hematology Healthcare Services
NAICS
Diagnostic Imaging Centers (621512), Medical and Diagnostic Laboratories (6215)
SIC
Services-Specialty Outpatient Facilities, Nec (8093), Services-Offices & Clinics Of Doctors Of Medicine (8011)
akta.pro primary industry
Ambulatory Oncology Centers (Outpatient Chemo/Radiation) (HLAFABAI)
akta.pro secondary industries
Nuclear Medicine Clinical Services & Therapy Centers (HLAIAGAI), Hospital-Integrated Cancer Centers (Acute Oncology Programs) (HLAFAAAM)

Keywords

  • Oncology services
  • Radiation therapy
  • Hematology care
  • Cancer treatment
  • Clinical trials

Where University Cancer & Blood Center is headquartered

Location

Headquarters

HQ city
Athens
HQ country
United States
HQ region
North America

Offices13 records

Markets served

University Cancer & Blood Center business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales, Supply Chain

Revenue model

  1. Patient Care Services: Revenue generated from comprehensive oncology and hematology healthcare services including medical oncology, radiation oncology, surgical oncology, diagnostic imaging, laboratory services, pharmacy, and supportive care. Billed through insurance reimbursement and patient payments.
  2. Clinical Trial Participation: Revenue and resources obtained through participation in clinical trials, providing access to investigational therapies while contributing to cancer research advancement.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels7 records

University Cancer & Blood Center product offering

Product offering

Core offering

University Cancer & Blood Center (UCBC) is a multi-specialty oncology and hematology practice delivering comprehensive cancer care including medical oncology, surgical oncology, radiation oncology, hematology, and specialized programs such as breast health, theranostics, melanoma, and high-risk GI clinics. The practice operates across 13 locations in Northeast Georgia with an Athens-based Comprehensive Cancer Center that co-locates infusion, imaging, laboratory, pharmacy, and supportive services.

Product overview

University Cancer & Blood Center (UCBC) is a multi-specialty oncology and hematology practice offering a comprehensive, vertically integrated cancer care ecosystem. The core portfolio consists of three primary treatment pillars—Medical Oncology (chemotherapy and drug-based therapies), Radiation Oncology (external beam, brachytherapy, and systemic radiopharmaceuticals), and Surgical Oncology—augmented by specialized programs including the Comprehensive Breast Health Program (3D mammography, breast surgery, lymphedema management), Theranostics (first in Georgia outside a hospital), Athens Brain Center, Melanoma Clinic, High-Risk GI Clinic, and Hematology services. UCBC delivers care through 13 area locations across Northeast Georgia, anchored by its Athens Comprehensive Cancer Center where private infusion, in-house laboratory, CT imaging, molecular testing, genetic counseling, UCBC Pharmacy, and the Acute Care Clinic are co-located. The Live Well integrative care program provides psychosocial, nutritional, and financial support, while an active Clinical Trials program spans 20+ cancer types. Patient-facing digital tools include a NavigatingCare patient portal and a bill payment portal, supported by an Inpatient APP program at affiliated hospitals. The organization traces its roots to Athens, Georgia since 1981.

Differentiator

Problem solved

Functional benefit

Products and services

  • Medical Oncology Comprehensive cancer treatment using chemotherapy, hormone therapy, and other drug-based therapies. UCBC oncologists guide patients through diagnosis, treatment planning, and post-treatment care.
  • Radiation Oncology Treatment using precisely targeted high-energy radiation to kill cancer cells, including external beam radiation therapy, brachytherapy, and systemic radiopharmaceuticals (LUTATHERA, Xofigo, Pluvicto).
  • Surgical Oncology Surgical removal of tumors and affected tissues, including liver, melanoma, pancreatic, gastrointestinal, retroperitoneal sarcoma, neuroendocrine tumors, and gallbladder cancers.
  • Hematology Treatment of benign and malignant blood disorders including anemias, blood transfusions, bone marrow transplantations, hemophilia, leukemias, lymphomas, multiple myeloma, and thrombotic conditions.
  • Comprehensive Breast Health Program Multidisciplinary breast health services including 3D mammography screening and diagnostics, high-risk breast program with genetic testing and counseling, breast surgery, medical and radiation oncology, and lymphedema management.
  • Theranostics First cancer center in Georgia to offer Theranostics outside a hospital setting, combining diagnostic PET scan imaging with targeted radiopharmaceutical therapy (LUTATHERA, Xofigo, Pluvicto) for neuroendocrine tumors and prostate cancer.
  • High-Risk GI Clinic Gastrointestinal cancer risk assessment, screening, and surveillance for patients with pre-cancerous conditions or genetic risk factors, including colorectal, gastric, or pancreatic cancers.
  • Melanoma Clinic Multidisciplinary melanoma treatment program involving dermatologists, medical oncologists, surgical oncologists, radiation oncologists, and ENT specialists, including SPECT imaging for lymph node identification.
  • Athens Brain Center Brain cancer treatment division offering radiation therapy and other advanced treatments for brain and spinal cord tumors, led by Dr. Gordon O. Schoenfeld.
  • Acute Care Clinic Same-day oncology urgent care clinic for UCBC patients experiencing adverse cancer treatment side effects, staffed by oncology-trained providers.
  • UCBC Pharmacy Full-service retail pharmacy within the Comprehensive Cancer Center staffed with certified pharmacists, accepting most major insurance and stocking difficult-to-find medications.
  • In-House Laboratory and Imaging Services In-house diagnostic capabilities including CT imaging, flow cytometry, molecular testing, and genetic counseling, enabling rapid diagnosis and treatment planning.
  • Live Well Integrative Care Program Holistic patient support program including integrative therapies, psychosocial counseling, nutrition counseling, palliative care, and financial support services.
  • Clinical Trials Program Active clinical trial program across 20+ cancer types, described as the second most prolific clinical trial facility in Georgia.
  • Inpatient Advanced Practice Provider Program On-site APP staff at Piedmont Athens and St. Mary's Hospitals serving as personal patient advocates to coordinate care for hospitalized UCBC patients.

Quantifiable outcome

  • 92% of breast cancer survivors had progression of secondary lymphedema stopped through three years using L-Dex Technology

Companies that use University Cancer & Blood Center

Customer profile

Named customers5 records

Segments4 records

Ideal customer profiles4 records

University Cancer & Blood Center technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

University Cancer & Blood Center partnerships and signals

Strategic signal

Partnerships

Eight partnerships are on record, tiered core, secondary and minor.

  • University Health AlliancecoreStrategic or Co-development Partner · 1 January 2024UCBC partnered with University Health Alliance to open the High-Risk GI Clinic, a state-of-the-art program featuring acclaimed physicians and experts in oncology and gastroenterology for patients at high risk of gastrointestinal cancer.
  • Cancer Foundation of Northeast GeorgiacoreStrategic or Co-development Partner · 1 January 2005UCBC established the Cancer Foundation of Northeast Georgia in 2005 to help offset the extreme financial burden that a cancer diagnosis and subsequent treatment can place on families. The foundation benefits not only UCBC patients but all those within the Northeast Georgia region, providing financial support services.
  • National Cancer Institute (NCI)coreStrategic or Co-development PartnerUCBC maintains affiliation with the National Cancer Institute (NCI), operating as a clinical trial site and part of a global community of cancer researchers working toward common goals in cancer treatment advancement.
  • Piedmont Athens RegionalcoreStrategic or Co-development PartnerUCBC's Inpatient APP staff are on-site as personal patient advocates at Piedmont Athens Hospital to coordinate care and optimize outcomes for UCBC patients receiving hospital treatment.
  • St. Mary's HospitalcoreStrategic or Co-development PartnerUCBC's Inpatient APP staff are on-site as personal patient advocates at St. Mary's Hospital to coordinate care and optimize outcomes for UCBC patients receiving hospital treatment.
  • ENT of AthenssecondaryStrategic or Co-development PartnerUCBC collaborates with ENT of Athens for multidisciplinary melanoma treatment, particularly for melanomas on the head and neck requiring facial plastic surgery expertise.
  • Dermatology SpecialistssecondaryStrategic or Co-development PartnerUCBC collaborates with dermatology specialists as part of the multidisciplinary melanoma clinic for skin assessment, biopsy, and ongoing dermatology care.
  • Choice Awards AthensminorOthersUCBC receives community recognition through Choice Awards Athens.

Scale indicators6 records

Recent moves9 records

Expansion highlights5 records

University Cancer & Blood Center competitors and assessment

Company assessment

Direct peers

  • Tennessee Oncology: Large independent community oncology practice serving Tennessee with medical, radiation, and gynecologic oncology across multiple locations. Closely comparable multi-site, physician-led oncology model serving a regional catchment area.
  • Florida Cancer Specialists & Research Institute: Largest independent oncology and hematology practice in the United States, operating nearly 100 locations across Florida. Closely comparable vertically integrated model with in-house lab, imaging, pharmacy, and clinical trials program.
  • Maryland Oncology Hematology: Independent community oncology practice operating across Maryland with medical oncology, radiation oncology, and clinical trials. Comparable multi-location, physician-led regional model with similar payer mix dynamics.
  • Oncology Hematology Care (OHC): Independently owned community oncology and hematology practice serving the Greater Cincinnati tri-state area. Directly comparable independent multi-specialty practice with infusion, clinical trials, and supportive care services.

Broad incumbents

  • American Oncology Network: PE-backed platform supporting independent community oncology practices with practice management, technology, and payer contracting. Relevant as both a competitor and a potential roll-up partner for UCBC.
  • OneOncology: PE-backed partnership platform for independent community oncology practices, providing capital, technology, and operational support. Comparable as a consolidation alternative facing UCBC.
  • Winship Cancer Institute of Emory University: National Cancer Institute-designated Comprehensive Cancer Center and academic oncology hub in metropolitan Atlanta. Direct competitor for complex oncology cases in UCBC's Georgia catchment, including for Theranostics and clinical trials.
  • The US Oncology Network: McKesson-affiliated network of independent community oncology practices offering practice management, technology, and drug distribution. Comparable as a competing affiliation model for community oncologists.

Regional players

  • Piedmont Cancer Institute: Hospital-affiliated oncology practice within the Piedmont Healthcare system in Georgia. Direct regional competitor sharing the same hospital partnership ecosystem as UCBC.
  • Northwest Georgia Oncology Centers: Independent community oncology practice serving Northwest Georgia and metro Atlanta suburbs. Comparable independent, multi-site model in a different but adjacent Georgia geography.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

University Cancer & Blood Center social profiles

Digital presence

University Cancer & Blood Center compliance and trust

Trust signal

Compliance5 records

University Cancer & Blood Center financial estimates

Financial estimate

Revenue estimate

Valuation estimate

University Cancer & Blood Center leadership team

Management profile

Number of profiles

Profiles6 records

University Cancer & Blood Center subsidiaries and ownership

Company hierarchy

Subsidiaries2 records

University Cancer & Blood Center funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

University Cancer & Blood Center M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about University Cancer & Blood Center

What does University Cancer & Blood Center do?

University Cancer & Blood Center (UCBC) is a multi-specialty oncology and hematology practice delivering comprehensive cancer care including medical oncology, surgical oncology, radiation oncology, hematology, and specialized programs such as breast health, theranostics, melanoma, and high-risk GI clinics. The practice operates across 13 locations in Northeast Georgia with an Athens-based Comprehensive Cancer Center that co-locates infusion, imaging, laboratory, pharmacy, and supportive services.

Is University Cancer & Blood Center a public or private company?

University Cancer & Blood Center is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was University Cancer & Blood Center founded?

University Cancer & Blood Center was founded in 1981. It employs 251 to 500 people.

Where is University Cancer & Blood Center based?

University Cancer & Blood Center is headquartered in Athens, United States, in the North America region.

How does University Cancer & Blood Center make money?

Two revenue lines are on record. Patient Care Services are the primary driver. The others are clinical Trial Participation.

Who are University Cancer & Blood Center's main competitors?

Direct peers on record are Tennessee Oncology, Florida Cancer Specialists & Research Institute, Maryland Oncology Hematology and Oncology Hematology Care (OHC). Broad incumbents are American Oncology Network, OneOncology, Winship Cancer Institute of Emory University and The US Oncology Network. Regional players are Piedmont Cancer Institute and Northwest Georgia Oncology Centers.

Does University Cancer & Blood Center have an API?

No public API is recorded for University Cancer & Blood Center.

What industry is University Cancer & Blood Center in?

University Cancer & Blood Center's product category is Oncology and Hematology Healthcare Services. Its primary akta.pro industry code is HLAFABAI, Ambulatory Oncology Centers (Outpatient Chemo/Radiation), with a secondary code of HLAIAGAI, Nuclear Medicine Clinical Services & Therapy Centers. Its NAICS code is 621512 and its SIC code is 8093.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
GlobeNewswireUniversity Cancer & Blood Center’s Dr. Ashley Ray receives oncoplastic breast surgery certificationDr. Ashley Ray, a breast surgeon at University Cancer & Blood Center, received certification in oncoplastic breast surgery from the National Consortium of Breast Centers. The certification combines cancer treatment with aesthetic reconstruction, and she is the first female fellowship-trained breast surgeon to practice in Athens.GlobeNewswireUniversity Cancer & Blood Center physicians recognized among Atlanta’s Top Doctors in Modern Luxury Medicine + Doctors magazineFour physicians from University Cancer & Blood Center were named Top Doctors in the January issue of Modern Luxury Medicine + Doctors magazine. The honor is peer-driven and includes Dr. Kuang Chang, Dr. Frederick Flynt, Dr. Jonathan Hsu, and Dr. Ashley Ray. The publication features 2,216 Top Doctors across Georgia counties.GlobeNewswireUniversity Cancer & Blood Center and University Health Alliance open High-Risk GI Clinic to address community needsUniversity Cancer & Blood Center and University Health Alliance opened a High-Risk GI Clinic in Athens and Watkinsville, Georgia, to provide early detection of GI cancers. The clinic offers streamlined procedures, genetic counseling, and risk reduction without physician referral. It aims to address pancreatic cancer, the third leading cause of cancer deaths.PR NewswireUniversity Cancer & Blood Center announces opening date of state-of-the art Comprehensive Cancer Treatment CenterUniversity Cancer & Blood Center (UCBC) announced it will open its new Comprehensive Cancer Treatment Center in Athens, Georgia, in August 2023. The 120,000-square-foot facility integrates medical, radiation, and surgical oncology services into a single location to streamline patient care.